Key result
Top-quartile HbA1c links to ~90% higher hypertension risk versus the lowest quartile in nondiabetics.
Why the study?
Abnormal glucose metabolism has been suggested to be involved in hypertension development, but the association and potential interaction of HbA1c and other factors on hypertension risk in Chinese nondiabetic adults required investigation.
Do elevated HbA1c levels increase the risk of hypertension in nondiabetic adults?
Cross-Sectional (n=1,462)
Do elevated HbA1c levels increase the risk of hypertension in nondiabetic adults?
Odds Ratio: 1.9 (95% CI 1.28–2.8)
p-value: p=<0.001
Higher HbA1c levels are associated with an increased risk of hypertension and isolated systolic hypertension in nondiabetic Chinese adults, with synergistic effects from abdominal obesity and family history.
May signal hypertension risk in nondiabetics; hypothesis-generating and should not yet change practice.
Background: Abnormal glucose metabolism has been suggested to be involved in the development of hypertension. This study investigated the effect of the association and potential interaction of glycosylated hemoglobin (HbA1c) and other factors on the risk of hypertension among Chinese nondiabetic adults. Methods : As a cross-sectional survey, the current work deployed a questionnaire survey, anthropometric tests, and biochemical measures for each of the eligible participants. The HbA1c levels were quantified and grouped by quartiles. Correlations between HbA1c and hypertension, isolated systolic hypertension (ISH), and isolated diastolic hypertension (IDH) risk in nondiabetics were investigated by univariate and multivariate logistic analyses. For evaluating the interactive effects, the parameters of relative excess risk due to interaction (RERI), attributable proportion due to interaction (AP), and synergy index (SI) were calculated, respectively. Results : In the current study, 1,462 nondiabetic subjects were enrolled. In total, the prevalence rates of hypertension, ISH and IDH were 22.4%, 9.6% and 4.5%, respectively. When HbA1c levels were grouped by quartile, it was revealed that the prevalence rates of hypertension and ISH were substantially elevated across groups (Pfor trend<0.001). In the multivariable logistic regression analyses, in comparison with the first quartile of HbA1c, the normalized OR for hypertension risk was 1.90 (95% CI: 1.28-2.80) for the highest quartile. Also, the risk of ISH was significantly increased with HbA1c level in the highest quartile relative to in the bottom quartile (OR: 2.23,95% CI:1.47-3.71). However, no significant relationship between the HbA1c level and IDH risk was observed (OR: 1.78, 95% CI: 0.82-3.84). Eventually, it was demonstrated from the interactive effect analysis that HbA1c significantly interacted with abdominal obesity(RERI: 1.48, 95% CI: 0.38-2.58; AP: 0.37, 95% CI: 0.14-0.60 and SI: 1.96, 95% CI: 1.06-3.62) and family history of hypertension(AP: 0.37, 95% CI: 0.05-0.70) in influencing the risk of hypertension in nondiabetic participants.Conclusion: Higher HbA1c levels were associated with an increased risk of hypertension and ISH, but not IDH among Chinese nondiabetic adults. Moreover, the risk of hypertension was also aggravated by the upregulated HbA1c in a synergistic manner alongside abdominal obesity and family history of hypertension.
No takes yet. Share an insight, caveat, or question.
Song et al. (2020) conducted a cross-sectional in Hypertension (n=1,462). Elevated glycosylated hemoglobin (HbA1c) levels vs. Lowest quartile of HbA1c was evaluated on Hypertension risk (highest vs lowest HbA1c quartile) (OR 1.90, 95% CI 1.28-2.80, p=<0.001). Elevated HbA1c levels in the highest quartile were associated with a significantly increased risk of hypertension compared to the lowest quartile in nondiabetic Chinese adults (OR 1.90).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: